Showing results (1-10 of 94) with videos related to
Sort By:
Pageof 10
Methods in Molecular Biology (Clifton, N.J.)|November 5, 2015
Microvesicles: Isolation, Characterization for In Vitro and In Vivo ProceduresKarmele Valencia, Fernando LecandaInternational Journal of Molecular Sciences|January 21, 2023
Cpt1c Downregulation Causes Plasma Membrane Remodelling and Anthracycline Resistance in Breast CancerHelena Muley, Karmele Valencia, Josefina Casas, et al.Translational Oncology|February 20, 2017
The Usefulness of Bone Biomarkers for Monitoring Treatment Disease: A Comparative Study in Osteolytic and Osteosclerotic Bone Metastasis ModelsMarta Martín-Fernández, Karmele Valencia, Carolina Zandueta, et al.Clinical & Experimental Metastasis|July 29, 2011
Tumor-stromal interactions of the bone microenvironment: in vitro findings and potential in vivo relevance in metastatic lung cancer modelsDiego Luis-Ravelo, Iker Antón, Silvestre Vicent, et al.Bone|November 13, 2012
miR-326 associates with biochemical markers of bone turnover in lung cancer bone metastasisKarmele Valencia, Marta Martín-Fernández, Carolina Zandueta, et al.Cancers|May 5, 2021
Exosomes in Liquid Biopsy: The Nanometric World in the Pursuit of Precision OncologyKarmele Valencia, Luis M MontuengaClinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 7, 2012
Inhibition of collagen receptor discoidin domain receptor-1 (DDR1) reduces cell survival, homing, and colonization in lung cancer bone metastasisKarmele Valencia, Cristina Ormazábal, Carolina Zandueta, et al.Molecular Oncology|December 11, 2013
RHOB influences lung adenocarcinoma metastasis and resistance in a host-sensitive mannerDiego Luis-Ravelo, Iker Antón, Carolina Zandueta, et al.Molecular & Cellular Oncology|June 16, 2017
All for one and FOSL1 for all: FOSL1 at the crossroads of lung and pancreatic cancer driven by mutant KRASAdrian Vallejo, Karmele Valencia, Silvestre VicentClinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 7, 2023
Estrogen Receptor and Immune Checkpoint Inhibitors: New Partners in Lung Cancer?Karmele Valencia, Luis M Montuenga, Alfonso CalvoPageof 10